Seeing Is Believing
Immunomedics's activity chart (see below) currently has 94 price targets and 75 ratings on display.
Analysts average stock forecasts to be materialized ratio is 95.45% with an average time for these price targets to be met of 188.36 days.
Most recent stock forecast was given by from JEFFERIES on 15-Sep-2020. First documented stock forecast 29-Jul-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 06-Oct-2016
$55
6 years 1 months 10 days ago
(15-Sep-2020)
5/5 (100%)
$11.69 (26.99%)
126
Buy Since 04-Mar-2019
$56
6 years 1 months 11 days ago
(14-Sep-2020)
9/9 (100%)
$14.84 (36.05%)
173
Buy Since 06-Jul-2020
$55
6 years 1 months 11 days ago
(14-Sep-2020)
5/5 (100%)
$14.37 (35.37%)
185
$40
$-47.86 (-54.47%)
$19
6 years 2 months 15 days ago
(10-Aug-2020)
5/5 (100%)
$-0.92 (-2.25%)
350
Buy Since 17-Sep-2018
$55
$-32.86 (-37.40%)
$52
6 years 2 months 19 days ago
(06-Aug-2020)
5/5 (100%)
$11.82 (27.37%)
173
What is IMMU (Immunomedics) average time for price targets to be met?
Which analyst most recently updated their price target on IMMU (Immunomedics)?
Which analyst has the most public recommendations on IMMU (Immunomedics)?
Which analyst is the currently most bullish on IMMU (Immunomedics)?
Which analyst is the currently most reserved on IMMU (Immunomedics)?